• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激素和代谢因素影响多囊卵巢综合征女性子宫内膜上孕酮的作用。

Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome.

作者信息

Baracat Maria Candida P, Baracat Edmund C, Simões Ricardo S, Simões Manuel J, Maciel Gustavo A R, Azziz Ricardo, Soares José Maria

机构信息

Disciplina de Ginecologia, Departamento de Obstetrícia e Ginecologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo 05403 000, Brazil.

Department of Obstetrics & Gynecology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

出版信息

Diagnostics (Basel). 2023 Jan 19;13(3):382. doi: 10.3390/diagnostics13030382.

DOI:10.3390/diagnostics13030382
PMID:36766487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9914468/
Abstract

Hormonal and metabolic factors may influence endometrial quality and interfere with the action of progesterone. Therefore, the aim of our study was to address this issue. Participants were recruited from an outpatient reproductive endocrinology clinic at an academic tertiary medical care centre. All subjects underwent endometrial biopsy (EB) in the follicular phase of the cycle prior to treatment. Thereafter, they were treated with micronized progesterone (400 mg/day × 10 days intravaginally) from days 14-28 of the next cycle. A second EB was performed between days 21-24 of the cycle (the second phase). The metabolic and hormonal serum levels were evaluated during the implantation window. EB samples were analysed using light microscopy for histomorphometric analysis. The endometrium of women with Polycystic Ovarian Syndrome (PCOS) in the second phase demonstrated a uniform surface epithelium with less leukocyte infiltration and an absence of apoptotic figures compared to the control group. ( < 0.021). The thickness of the surface epithelium in the second phase of the PCOS group correlated positively with free and bioavailable testosterone values. The number of stromal cells increases with increasing insulin levels. Our results suggest that histomorphometric abnormalities of the endometrium persist and are linked to androgen and insulin levels despite progesterone supplementation in PCOS.

摘要

激素和代谢因素可能会影响子宫内膜质量,并干扰孕酮的作用。因此,我们研究的目的是解决这个问题。参与者从一所学术性三级医疗中心的门诊生殖内分泌诊所招募。所有受试者在治疗前的月经周期卵泡期接受子宫内膜活检(EB)。此后,在下一个周期的第14 - 28天,他们接受微粉化孕酮治疗(400毫克/天,经阴道给药10天)。在月经周期的第21 - 24天(第二阶段)进行第二次EB。在着床窗口期评估代谢和激素血清水平。EB样本使用光学显微镜进行组织形态计量学分析。与对照组相比,多囊卵巢综合征(PCOS)女性在第二阶段的子宫内膜显示出表面上皮均匀,白细胞浸润较少且无凋亡细胞(<0.021)。PCOS组第二阶段表面上皮的厚度与游离和生物可利用睾酮值呈正相关。基质细胞数量随着胰岛素水平的升高而增加。我们的结果表明,尽管PCOS患者补充了孕酮,但子宫内膜的组织形态计量学异常仍然存在,并且与雄激素和胰岛素水平有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade7/9914468/e3b1ec17c5e7/diagnostics-13-00382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade7/9914468/4aee40664294/diagnostics-13-00382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade7/9914468/3e1fcd406123/diagnostics-13-00382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade7/9914468/e3b1ec17c5e7/diagnostics-13-00382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade7/9914468/4aee40664294/diagnostics-13-00382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade7/9914468/3e1fcd406123/diagnostics-13-00382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade7/9914468/e3b1ec17c5e7/diagnostics-13-00382-g004.jpg

相似文献

1
Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome.激素和代谢因素影响多囊卵巢综合征女性子宫内膜上孕酮的作用。
Diagnostics (Basel). 2023 Jan 19;13(3):382. doi: 10.3390/diagnostics13030382.
2
Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations.子宫功能:从正常到多囊卵巢综合征的改变。
Curr Med Chem. 2018;25(15):1792-1804. doi: 10.2174/0929867325666171205144119.
3
Pituitary, ovarian and endometrial effects of progesterone released prematurely during the proliferative phase.增殖期过早释放的孕酮对垂体、卵巢和子宫内膜的影响。
Contraception. 1983 Feb;27(2):177-93. doi: 10.1016/0010-7824(83)90088-4.
4
Histomorphometric Analysis and Markers of Endometrial Receptivity Embryonic Implantation in Women With Polycystic Ovary Syndrome During the Treatment With Progesterone.多囊卵巢综合征女性在孕激素治疗期间子宫内膜容受性及胚胎着床的组织形态计量学分析与标志物研究
Reprod Sci. 2014 Jul;21(7):930-938. doi: 10.1177/1933719113519169. Epub 2014 Jan 23.
5
Scaffold-Free Endometrial Organoids Respond to Excess Androgens Associated With Polycystic Ovarian Syndrome.无支架子宫内膜类器官对多囊卵巢综合征相关雄激素过多有反应。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):769-80. doi: 10.1210/clinem/dgz100.
6
Endometrium in PCOS: Implantation and predisposition to endocrine CA.多囊卵巢综合征中的子宫内膜:着床与内分泌癌易感性
Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):235-44. doi: 10.1016/j.beem.2006.03.005.
7
Artificial intelligence deep learning model assessment of leukocyte counts and proliferation in endometrium from women with and without polycystic ovary syndrome.人工智能深度学习模型评估多囊卵巢综合征患者和非多囊卵巢综合征患者子宫内膜中的白细胞计数和增殖情况。
F S Sci. 2022 May;3(2):174-186. doi: 10.1016/j.xfss.2022.01.006. Epub 2022 Jan 22.
8
Effects of clinical and metabolic variables and hormones on the expression of immune protein biomarkers in the endometrium of women with polycystic ovary syndrome and normal-cycling controls.多囊卵巢综合征患者和正常排卵对照妇女子宫内膜中免疫蛋白生物标志物表达的临床和代谢变量及激素的影响。
Gynecol Endocrinol. 2022 Jun;38(6):508-515. doi: 10.1080/09513590.2022.2061454. Epub 2022 Apr 8.
9
Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.生活方式干预可上调超重/肥胖多囊卵巢综合征妇女子宫内膜中胰岛素信号转导相关分子的基因和蛋白水平。
Hum Reprod. 2014 Jul;29(7):1526-35. doi: 10.1093/humrep/deu114. Epub 2014 May 19.
10
Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium.多囊卵巢综合征与子宫内膜异常之间机制的研究进展
Front Physiol. 2021 Dec 17;12:788772. doi: 10.3389/fphys.2021.788772. eCollection 2021.

引用本文的文献

1
Role of atherogenic indices in predicting infertility in polycystic ovary syndrome.致动脉粥样硬化指数在预测多囊卵巢综合征患者不孕中的作用。
Rev Assoc Med Bras (1992). 2025 Aug 8;71(7):e20241460. doi: 10.1590/1806-9282.20241460. eCollection 2025.
2
Investigation of serum agouti-related peptide levels in women with polycystic ovary syndrome.多囊卵巢综合征女性血清刺鼠相关肽水平的研究。
Rev Assoc Med Bras (1992). 2025 Jun 16;71(5):e20241836. doi: 10.1590/1806-9282.20241836. eCollection 2025.
3
Obstructive sleep apnea risk and sleep quality in adolescents with polycystic ovary syndrome: a case-control study.

本文引用的文献

1
Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system.雌激素、多态性、转录因子、表观遗传改变及泛素-蛋白酶体系统对子宫内膜异位症、子宫内膜癌和乳腺癌中孕激素受体表达的调控
J Steroid Biochem Mol Biol. 2023 Mar;227:106199. doi: 10.1016/j.jsbmb.2022.106199. Epub 2022 Sep 30.
2
Key signalling pathways underlying the aetiology of polycystic ovary syndrome.多囊卵巢综合征发病机制中的关键信号通路。
J Endocrinol. 2022 Sep 7;255(1):R1-R26. doi: 10.1530/JOE-22-0059. Print 2022 Oct 1.
3
多囊卵巢综合征青少年的阻塞性睡眠呼吸暂停风险与睡眠质量:一项病例对照研究。
Rev Assoc Med Bras (1992). 2025 Jun 2;71(4):e20241615. doi: 10.1590/1806-9282.20241615. eCollection 2025.
4
The relationship between spexin and liver steatosis in polycystic ovary syndrome: a novel analysis using ultrasound-guided attenuation parameter.多囊卵巢综合征中斯皮辛与肝脏脂肪变性的关系:一项使用超声引导衰减参数的新分析
Rev Assoc Med Bras (1992). 2025 Mar 31;71(2):e20241313. doi: 10.1590/1806-9282.20241313. eCollection 2025.
5
Polycystic ovary syndrome: emerging stem cell therapies.多囊卵巢综合征:新兴的干细胞疗法。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(6):e20231436. doi: 10.1590/1806-9282.20231436. eCollection 2024.
6
The association of CYP11A1 gene polymorphisms with the polycystic ovary syndrome patients.CYP11A1 基因多态性与多囊卵巢综合征患者的关联。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(7):e20231293. doi: 10.1590/1806-9282.20231293. eCollection 2024.
7
Effect of polycystic ovary syndrome on the life quality of young women.多囊卵巢综合征对年轻女性生活质量的影响。
Rev Assoc Med Bras (1992). 2024 May 3;70(4):e20231368. doi: 10.1590/1806-9282.20231368. eCollection 2024.
8
Is polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study.多囊卵巢综合征是抑郁和焦虑的危险因素吗?一项横断面研究。
Rev Assoc Med Bras (1992). 2024 Apr 22;70(3):e20230918. doi: 10.1590/1806-9282.20230918. eCollection 2024.
9
Influence of Phenotypes on the Metabolic Syndrome of Women with Polycystic Ovary Syndrome over a Six-Year Follow-Up in Brazil.巴西六年随访期间多囊卵巢综合征女性的表型对代谢综合征的影响。
Biomedicines. 2023 Dec 9;11(12):3262. doi: 10.3390/biomedicines11123262.
10
Breast cancer survivals and hormone therapy: estrogen and melatonin.乳腺癌幸存者与激素疗法:雌激素和褪黑素
Rev Assoc Med Bras (1992). 2023 Sep 25;69(10):e6910EDI. doi: 10.1590/1806-9282.6910EDI. eCollection 2023.
Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome.
多囊卵巢综合征中子宫内膜容受性异常与氧化应激
Front Pharmacol. 2022 Jul 25;13:904942. doi: 10.3389/fphar.2022.904942. eCollection 2022.
4
Effects of clinical and metabolic variables and hormones on the expression of immune protein biomarkers in the endometrium of women with polycystic ovary syndrome and normal-cycling controls.多囊卵巢综合征患者和正常排卵对照妇女子宫内膜中免疫蛋白生物标志物表达的临床和代谢变量及激素的影响。
Gynecol Endocrinol. 2022 Jun;38(6):508-515. doi: 10.1080/09513590.2022.2061454. Epub 2022 Apr 8.
5
Identification of polycystic ovary syndrome from blood serum using hormone levels via Raman spectroscopy and multivariate analysis.基于拉曼光谱和多元分析的血清激素水平鉴定多囊卵巢综合征。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 May 15;273:121029. doi: 10.1016/j.saa.2022.121029. Epub 2022 Feb 18.
6
Progesterone Actions and Resistance in Gynecological Disorders.孕激素在妇科疾病中的作用及其抵抗机制。
Cells. 2022 Feb 13;11(4):647. doi: 10.3390/cells11040647.
7
Effectiveness and safety of aspirin combined with letrozole in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis.阿司匹林联合来曲唑治疗多囊卵巢综合征的有效性和安全性:系统评价和荟萃分析。
Ann Palliat Med. 2021 Apr;10(4):4632-4641. doi: 10.21037/apm-21-606.
8
Letrozole Versus Clomiphene Citrate and Natural Cycle: Endometrial Receptivity During Implantation Window in Women With Polycystic Ovary Syndrome.来曲唑对比枸橼酸氯米酚与自然周期:多囊卵巢综合征患者种植窗期子宫内膜容受性。
Front Endocrinol (Lausanne). 2021 Jan 18;11:532692. doi: 10.3389/fendo.2020.532692. eCollection 2020.
9
Endometrial function in women with polycystic ovary syndrome: a comprehensive review.多囊卵巢综合征女性的子宫内膜功能:综合评述。
Hum Reprod Update. 2021 Apr 21;27(3):584-618. doi: 10.1093/humupd/dmaa051.
10
Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome.来曲唑在多囊卵巢综合征患者的促排卵治疗中优于枸橼酸氯米芬。
Pak J Med Sci. 2020 Nov-Dec;36(7):1460-1465. doi: 10.12669/pjms.36.7.3345.